查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771493

全球性行為感染(STI) 和陰道炎 PCR 檢測市場：市場規模、佔有率、趨勢分析（按症狀、檢測類型、最終用途和地區）、細分市場預測（2025-2030 年）

STI And Vaginitis PCR Testing Market Size, Share & Trends Analysis Report By Condition (Sexually Transmitted Infections, Vaginal Infections), By Test Type (STI PCR Panels, Vaginitis PCR Panels), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 179 Pages | 商品交期: 2-10個工作天內

價格

性行為感染傳染病和陰道炎PCR檢測：市場趨勢

2024 年全球性行為感染感染 (STI) 和陰道炎 PCR 檢測市值估計為 6.6097 億美元，預計到 2030 年將達到 11.119 億美元，2025 年至 2030 年的複合年成長率為 9.21%。

這是在全球性行為感染和陰道感染疾病不斷增加的背景下發生的。

大眾對性與生殖健康的認知不斷提高，以及對 PCR 檢測等高靈敏度分子診斷方法的日益偏好，是市場擴張的主要驅動力。根據 CDC 2023 年的數據，美國診斷和報告的偏好、淋病和披衣菌感染病例超過 240 萬例，其中包括超過 209,000 例梅毒、超過 60 萬例淋病和超過 160 萬例披衣菌感染。此外，預計在預測期內，家用檢測套組的普及、多重 PCR 檢測技術的進步以及公共衛生基礎設施投資的增加將進一步推動市場成長。

開發中地區性傳染感染和陰道炎的發生率尤其激增，這主要是由於衛生基礎設施不足和篩檢項目有限。都市化、人口遷移和高風險性行為加劇了疾病負擔。這些因素促使人們需要易於取得、靈敏度高、能夠處理大量樣本並提供可靠結果的診斷工具。 PCR檢測能夠檢測低水平的病原體DNA或RNA，有效地滿足了這些需求，並在此類全部區域公共衛生篩檢舉措中得到了越來越多的應用。

新型PCR診斷檢測的法規核准將顯著影響性行為感染和陰道炎PCR檢測產業的成長軌跡。獲得美國食品藥物管理局(FDA)、歐洲藥品管理局 (EMA) 和其他區域機構等機構的核准，將有助於快速進入市場，並增強醫療服務提供者的信心。近期核准的多重PCR套件可在一次檢測中檢測多種性傳染感染和陰道炎病原體，這將簡化診斷流程，提高臨床工作流程的效率。這些獲批產品樹立了品質和性能的標桿，促進了其廣泛應用。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章。性行為感染傳染病和陰道炎 PCR 檢測市場：促進因素、趨勢和範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 性行為感染傳染病和陰道炎PCR檢測市場：分析工具
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL分析

第4章性行為感染傳染病和陰道炎 PCR 檢測市場：按症狀的估計和趨勢分析

  • 按條件分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板
  • 全球性行為感染傳染病和陰道炎 PCR 檢測市場：按症狀分類的展望
  • 市場規模預測及趨勢分析（2018年及2030年）
    • 性行為感染感染（STI）
    • 陰道感染疾病

第5章性行為感染傳染病和陰道炎 PCR 檢測市場：按檢測類型估算和趨勢分析

  • 按測試類型分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板
  • 全球性行為感染傳染病與陰道炎 PCR 檢測市場：按檢測類型分類的展望
  • 市場規模預測及趨勢分析（2018年及2030年）
    • 性傳染感染 PCR 檢測板
    • 陰道炎PCR檢測

第6章。性行為感染傳染病和陰道炎 PCR 檢測市場：按最終用途的估計和趨勢分析

  • 按最終用途分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板
  • 全球性行為感染和陰道感染 PCR 檢測市場：按最終用途分類的前景
  • 市場規模預測及趨勢分析（2018年及2030年）
    • 醫院和診所
    • 診斷實驗室
    • 居家醫療/家庭檢測
    • 其他

第7章性行為感染傳染病和陰道炎 PCR 檢測市場：按地區估計和趨勢分析

  • 各地區市場佔有率（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 市場規模預測及趨勢分析（2018年及2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
    • 葡萄牙
    • 土耳其
    • 斯洛維尼亞
    • 愛沙尼亞
    • 瑞典
    • 芬蘭
    • 拉脫維亞
    • 立陶宛
    • 波蘭
    • 俄羅斯
    • 烏克蘭
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 馬來西亞
    • 印尼
    • 越南
    • 台灣
    • 泰國
    • 蒙古
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 厄瓜多
    • 秘魯
  • 中東和非洲
    • 非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業市場佔有率分析（2024年）
    • BD
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Abbott
    • Danaher Corporation（Cepheid）
    • Seegene Inc.
    • bioMerieux（BioFire Diagnostics）
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • DiaSorin SpA（Luminex）
    • Sansure Biotech Inc.
    • R-Biopharm AG
    • altona Diagnostics GmbH
    • CERTEST BIOTEC
Product Code: GVR-4-68040-608-9

STI And Vaginitis PCR Testing Market Trends:

The global STI and vaginitis PCR testing market size was estimated at USD 660.97 million in 2024 and is projected to reach USD 1,111.9 million by 2030, growing at a CAGR of 9.21% from 2025 to 2030. This is attributed to the rising global incidence of sexually transmitted and vaginal infections.

Increasing public awareness of sexual and reproductive health, and the increasing preference for highly sensitive molecular diagnostic methods such as PCR testing, significantly drive the market expansion. According to CDC data in 2023, more than 2.4 million cases of syphilis, gonorrhea, and chlamydia were diagnosed and reported in the U.S. This total comprised over 209,000 cases of syphilis, more than 600,000 cases of gonorrhea, and upwards of 1.6 million cases of chlamydia. Additionally, expanding access to at-home testing kits, technological advancements in multiplex PCR assays, and greater investment in public health infrastructure are expected to further drive market growth over the forecast period.

Developing regions are witnessing particularly sharp increases in STIs and vaginitis prevalence, primarily due to inadequate healthcare infrastructure and limited screening programs. Urbanization, migration, and high-risk sexual practices contribute to this rising disease burden. These factors increase the need for accessible, sensitive diagnostic tools capable of handling high sample volumes and delivering reliable results. With its ability to detect low levels of pathogen DNA or RNA, PCR testing meets these demands effectively and is increasingly adopted in public health screening initiatives across such regions.

Regulatory approvals for new PCR diagnostic tests significantly impact the growth trajectory of the STI and vaginitis PCR testing industry. Obtaining approvals from authorities such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional bodies facilitates faster market access and builds confidence among healthcare providers. Recent approvals of multiplex PCR kits that detect multiple STIs and vaginitis-causing pathogens in a single test streamline the diagnostic process, enhancing clinical workflow efficiency. These authorized products set quality and performance benchmarks that encourage widespread adoption.

Global STI And Vaginitis PCR Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global STI and vaginitis PCR testing market report based on condition, test type, end-use, and region:

  • Condition Outlook (Revenue, USD Million, 2018 - 2030)
  • Sexually Transmitted Infections (STIs)
    • Chlamydia
    • Gonorrhea
    • Trichomoniasis
    • Herpes Simplex Virus (HSV-1 & HSV-2)
    • Human Papillomavirus (HPV)
    • Syphilis
    • Other
  • Vaginal Infections
    • Bacterial Vaginosis
    • Vulvovaginal Candidiasis
    • Other
  • Test type Outlook (Revenue, USD Million, 2018 - 2030)
  • STI PCR Panels
  • Vaginitis PCR Panels
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Homecare/At-home Testing
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Portugal
    • Hungary
    • Turkey
    • Slovenia
    • Norway
    • Denmark
    • Sweden
    • Estonia
    • Finland
    • Latvia
    • Lithuania
    • Poland
    • Russia
    • Ukraine
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • Malaysia
    • Indonesia
    • Vietnam
    • Taiwan
    • Mongolia
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Ecuador
    • Peru
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Africa

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Condition
    • 1.2.2. Test Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
  • 1.5. Primary research
    • 1.5.1. Details of primary research
      • 1.5.1.1. Data for primary interviews in North America
      • 1.5.1.2. Data for primary interviews in Europe
      • 1.5.1.3. Data for primary interviews in Asia Pacific
      • 1.5.1.4. Data for primary interviews in Latin America
      • 1.5.1.5. Data for Primary interviews in MEA
    • 1.5.2. Information or Data Analysis
    • 1.5.3. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Condition outlook
    • 2.2.2. Test Type Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. STI and vaginitis PCR testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of STIs and vaginitis infections fuels market demand
      • 3.2.1.2. Regulatory approvals accelerate market adoption and innovation
      • 3.2.1.3. Technological advancements enhance accuracy and accessibility of PCR testing
      • 3.2.1.4. Growing awareness and screening programs boost early diagnosis rates
  • 3.3. Market Restraint Analysis
      • 3.3.1.1. High cost of PCR testing limits market penetration
      • 3.3.1.2. Lack of skilled personnel and infrastructure challenges
      • 3.3.1.3. Privacy concerns and social stigma affect testing rates
  • 3.4. STI and vaginitis PCR testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTEL Analysis

Chapter 4. STI and vaginitis PCR testing Market: Condition Estimates & Trend Analysis

  • 4.1. Condition Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global STI and vaginitis PCR testing Market by Condition Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Sexually Transmitted Infections (STIs)
      • 4.4.1.1. STI's market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Chlamydia
        • 4.4.1.2.1. Chlamydia market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Gonorrhea
        • 4.4.1.3.1. Gonorrhea market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Trichomoniasis
        • 4.4.1.4.1. Trichomoniasis market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Herpes Simplex Virus (HSV-1 & HSV-2)
        • 4.4.1.5.1. HSV market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.6. Human Papillomavirus (HPV)
        • 4.4.1.6.1. HPV market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.7. Syphilis
        • 4.4.1.7.1. Syphilis market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.8. Other
        • 4.4.1.8.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Vaginal Infections
      • 4.4.2.1. Vaginal infections market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Bacterial Vaginosis
        • 4.4.2.2.1. Bacterial Vaginosis market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Vulvovaginal Candidiasis
        • 4.4.2.3.1. Vulvovaginal Candidiasis market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Other
      • 4.4.2.5. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. STI and vaginitis PCR testing Market: Test Type Estimates & Trend Analysis

  • 5.1. Test Type Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global STI and vaginitis PCR testing Market by Test Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. STI PCR Panels
      • 5.4.1.1. STI PCR panels market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Vaginitis PCR Panels
        • 5.4.2.1.1. Vaginitis PCR panels market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. STI and vaginitis PCR testing Market: End use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global STI and vaginitis PCR testing Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals and Clinics
      • 6.4.1.1. Hospitals and Clinics market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Diagnostic Laboratories
      • 6.4.2.1. Diagnostic Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Homecare/At-home Testing
      • 6.4.3.1. Homecare/At-home Testing market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. STI and Vaginitis PCR Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts, Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Portugal
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework/ reimbursement structure
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Portugal market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.10. Turkey
      • 7.6.10.1. Key country dynamics
      • 7.6.10.2. Regulatory framework/ reimbursement structure
      • 7.6.10.3. Competitive scenario
      • 7.6.10.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.11. Slovenia
      • 7.6.11.1. Key country dynamics
      • 7.6.11.2. Regulatory framework/ reimbursement structure
      • 7.6.11.3. Competitive scenario
      • 7.6.11.4. Slovenia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.12. Estonia
      • 7.6.12.1. Key country dynamics
      • 7.6.12.2. Regulatory framework/ reimbursement structure
      • 7.6.12.3. Competitive scenario
      • 7.6.12.4. Estonia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.13. Sweden
      • 7.6.13.1. Key country dynamics
      • 7.6.13.2. Regulatory framework/ reimbursement structure
      • 7.6.13.3. Competitive scenario
      • 7.6.13.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.14. Finland
      • 7.6.14.1. Key country dynamics
      • 7.6.14.2. Regulatory framework/ reimbursement structure
      • 7.6.14.3. Competitive scenario
      • 7.6.14.4. Finland market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.15. Latvia
      • 7.6.15.1. Key country dynamics
      • 7.6.15.2. Regulatory framework/ reimbursement structure
      • 7.6.15.3. Competitive scenario
      • 7.6.15.4. Latvia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.16. Lithuania
      • 7.6.16.1. Key country dynamics
      • 7.6.16.2. Regulatory framework/ reimbursement structure
      • 7.6.16.3. Competitive scenario
      • 7.6.16.4. Lithuania market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.17. Poland
      • 7.6.17.1. Key country dynamics
      • 7.6.17.2. Regulatory framework/ reimbursement structure
      • 7.6.17.3. Competitive scenario
      • 7.6.17.4. Poland market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.18. Russia
      • 7.6.18.1. Key country dynamics
      • 7.6.18.2. Regulatory framework/ reimbursement structure
      • 7.6.18.3. Competitive scenario
      • 7.6.18.4. Russia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.19. Ukraine
      • 7.6.19.1. Key country dynamics
      • 7.6.19.2. Regulatory framework/ reimbursement structure
      • 7.6.19.3. Competitive scenario
      • 7.6.19.4. Ukraine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Malaysia
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework/ reimbursement structure
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Malaysia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.8. Indonesia
      • 7.7.8.1. Key country dynamics
      • 7.7.8.2. Regulatory framework/ reimbursement structure
      • 7.7.8.3. Competitive scenario
      • 7.7.8.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.9. Vietnam
      • 7.7.9.1. Key country dynamics
      • 7.7.9.2. Regulatory framework/ reimbursement structure
      • 7.7.9.3. Competitive scenario
      • 7.7.9.4. Vietnam market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.10. Taiwan
      • 7.7.10.1. Key country dynamics
      • 7.7.10.2. Regulatory framework/ reimbursement structure
      • 7.7.10.3. Competitive scenario
      • 7.7.10.4. Taiwan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.11. Thailand
      • 7.7.11.1. Key country dynamics
      • 7.7.11.2. Regulatory framework/ reimbursement structure
      • 7.7.11.3. Competitive scenario
      • 7.7.11.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.12. Mongolia
      • 7.7.12.1. Key country dynamics
      • 7.7.12.2. Regulatory framework/ reimbursement structure
      • 7.7.12.3. Competitive scenario
      • 7.7.12.4. Mongolia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Colombia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Chile
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework/ reimbursement structure
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Chile market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Ecuador
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework/ reimbursement structure
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Ecuador market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.6. Peru
      • 7.8.6.1. Key country dynamics
      • 7.8.6.2. Regulatory framework/ reimbursement structure
      • 7.8.6.3. Competitive scenario
      • 7.8.6.4. Peru market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
    • 8.3.2. BD
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. F. Hoffmann-La Roche Ltd.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Hologic, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Abbott
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Danaher Corporation (Cepheid)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Seegene Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. bioMerieux (BioFire Diagnostics)
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. QIAGEN
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Thermo Fisher Scientific, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. DiaSorin S.p.A (Luminex)
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Sansure Biotech Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. R-Biopharm AG
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. altona Diagnostics GmbH
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. CERTEST BIOTEC
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global STI and Vaginitis PCR Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 6 Global STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 7 Global STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 10 North America STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 11 North America STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 13 U.S. STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 16 Canada STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 17 Canada STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Mexico STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 19 Mexico STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 20 Mexico STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Europe STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 23 Europe STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 Europe STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 UK STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 26 UK STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 27 UK STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Germany STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 29 Germany STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 30 Germany STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 France STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 32 France STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 33 France STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Italy STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 35 Italy STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 36 Italy STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Spain STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 38 Spain STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 39 Spain STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Denmark STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 41 Denmark STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 42 Denmark STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Sweden STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 44 Sweden STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 45 Sweden STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Norway STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 47 Norway STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 48 Norway STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Portugal STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 50 Portugal STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 51 Portugal STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Hungary STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 53 Hungary STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 54 Hungary STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55 Turkey STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 56 Turkey STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 57 Turkey STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58 Slovenia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 59 Slovenia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 60 Slovenia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Estonia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 62 Estonia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 63 Estonia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 64 Finland STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 65 Finland STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 66 Finland STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67 Latvia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 68 Latvia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 69 Latvia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 70 Lithuania STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 71 Lithuania STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 72 Lithuania STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 Poland STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 74 Poland STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 75 Poland STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 76 Russia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 77 Russia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 78 Russia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 79 Ukraine STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 80 Ukraine STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 81 Ukraine STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 Asia Pacific STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 84 Asia Pacific STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 Asia Pacific STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 86 Japan STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 87 Japan STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 88 Japan STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 89 China STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 90 China STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 91 China STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 92 India STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 93 India STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 94 India STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 95 South Korea STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 96 South Korea STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 97 South Korea STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 98 Australia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 99 Australia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 100 Australia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 101 Thailand STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 102 Thailand STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 103 Thailand STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 104 Malaysia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 105 Malaysia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 106 Malaysia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107 Indonesia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 108 Indonesia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 109 Indonesia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 110 Vietnam STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 111 Vietnam STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 112 Vietnam STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 113 Taiwan STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 114 Taiwan STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 115 Taiwan STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 116 Mongolia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 117 Mongolia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 118 Mongolia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 119 Latin America STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 120 Latin America STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 121 Latin America STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 122 Latin America STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 123 Brazil STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 124 Brazil STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 125 Brazil STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 126 Argentina STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 127 Argentina STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 128 Argentina STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 129 Colombia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 130 Colombia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 131 Colombia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 132 Chile STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 133 Chile STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 134 Chile STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 135 Ecuador STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 136 Ecuador STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 137 Ecuador STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 138 Peru STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 139 Peru STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 140 Peru STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 141 Middle East and Africa STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 142 Middle East and Africa STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 143 Middle East and Africa STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 144 Middle East & Africa STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 145 South Africa STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 146 South Africa STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 147 South Africa STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 148 Saudi Arabia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 149 Saudi Arabia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 150 Saudi Arabia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 151 UAE STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 152 UAE STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 153 UAE STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 154 Kuwait STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
  • Table 155 Kuwait STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 156 Kuwait STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 STI and vaginitis PCR testing market segment scope and definition
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 STI and Vaginitis PCR Testing market: Condition movement analysis
  • Fig. 17 STI and Vaginitis PCR Testing market: Condition segment dashboard
  • Fig. 18 STI and vaginitis PCR testing market Condition outlook: Key takeaways
  • Fig. 19 Sexually Transmitted Infections (STIs) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Trichomoniasis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Herpes Simplex Virus (HSV-1 & HSV-2) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Human Papillomavirus (HPV) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Syphilis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Vaginal infections market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Bacterial Vaginosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Vulvovaginal Candidiasis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 STI and Vaginitis PCR Testing market: Test Type movement analysis
  • Fig. 32 STI and vaginitis PCR testing market Test Type outlook: Key takeaways
  • Fig. 33 STI PCR panels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Vaginitis PCR panels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 STI and Vaginitis PCR Testing market: End use movement analysis
  • Fig. 36 STI and vaginitis PCR testing market End use outlook: Key takeaways
  • Fig. 37 Hospitals and Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Diagnostic Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Homecare/At-home Testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Regional outlook, 2024 & 2030
  • Fig. 42 Regional market dashboard
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 North America STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Canada STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 UK STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 France STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Portugal STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Hungary STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Turkey STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 Slovenia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Estonia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 62 Finland STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 63 Latvia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 64 Lithuania STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 65 Poland STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 66 Russia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 67 Ukraine STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 69 Japan STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 70 China STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 71 India STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 72 South Korea STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 73 Australia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 75 Malaysia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 76 Indonesia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 77 Vietnam STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 78 Taiwan STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 79 Mongolia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 83 Colombia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 84 Chile STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 85 Ecuador STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 86 Peru STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 87 MEA STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 88 Africa STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 90 UAE STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 91 Kuwait STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
  • Fig. 92 Heat map analysis
  • Fig. 93 Market differentiators